Circulating tumour-derived microvesicles in plasma of gastric cancer patients

[1]  T. Tadros.  General Principles of Colloid Stability and the Role of Surface Forces , 2011 .

[2]  M. Panaro,et al.  Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. , 2009, Cancer research.

[3]  S. Brodsky,et al.  Dynamics of circulating microparticles in liver transplant patients. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[4]  P. Galle,et al.  Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. , 2008, World Journal of Gastroenterology.

[5]  A. Iglič,et al.  Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases. , 2008, Blood cells, molecules & diseases.

[6]  E. Thiel,et al.  Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer , 2008, Journal of Cancer Research and Clinical Oncology.

[7]  J. Stachura,et al.  Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression. , 2008, Oncology reports.

[8]  H. Tsuda,et al.  Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer , 2008, Journal of surgical oncology.

[9]  K. Węglarczyk,et al.  Tumour-derived microvesicles modulate biological activity of human monocytes. , 2007, Immunology letters.

[10]  H. Kwon,et al.  Proteomic analysis of microvesicles derived from human colorectal cancer cells. , 2007, Journal of proteome research.

[11]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[12]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[13]  M. Zembala,et al.  Polyelectrolyte adsorption layers studied by streaming potential and particle deposition. , 2006, Journal of colloid and interface science.

[14]  Claudia Rubie,et al.  Chemokine receptor CCR6 expression in colorectal liver metastasis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Villa,et al.  Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. , 2006, Cancer research.

[16]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[17]  M. Ratajczak,et al.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes , 2006, Cancer Immunology, Immunotherapy.

[18]  T. Whiteside,et al.  Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. , 2006, Seminars in cancer biology.

[19]  Graça Raposo,et al.  Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.

[20]  G. Parmiani,et al.  Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. , 2005, Gastroenterology.

[21]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[22]  Simon C Watkins,et al.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  D. Taylor,et al.  Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects , 2005, British Journal of Cancer.

[24]  M. Martínez-Lorenzo,et al.  The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack. , 2004, Experimental cell research.

[25]  L. Horstman,et al.  Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.

[26]  G. Ostroff,et al.  Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. , 2003, Cancer research.

[27]  K. Shedden,et al.  Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. , 2003, Cancer research.

[28]  藤間 聡.  Activated Polymorphonuclear Leukocytes Enhance Production of Leukocyte Microparticles with Increased Adhesion Molecules in Patients with Sepsis , 2003 .

[29]  S. Nomura,et al.  Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. , 2003, Lung cancer.

[30]  R. Nieuwland,et al.  Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.

[31]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[32]  M. Raffeld,et al.  Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness. , 2002, Cancer research.

[33]  F. Tanaka,et al.  Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. , 2002, Cancer research.

[34]  V. Dolo,et al.  Membrane vesicles in ovarian cancer fluids: a new potential marker. , 1999, Anticancer research.

[35]  D. Taylor,et al.  Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies , 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

[36]  K. Song,et al.  Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. , 2009, International journal of oncology.

[37]  M. Gelderman,et al.  Flow cytometric analysis of cell membrane microparticles. , 2008, Methods in molecular biology.

[38]  G. Parmiani,et al.  Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.

[39]  J. Stachura,et al.  Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer. , 2007, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[40]  M. Gelderman,et al.  Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. , 2006, Transfusion medicine reviews.

[41]  T. Whiteside,et al.  Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles , 2006, Immunologic research.

[42]  L. Zitvogel,et al.  Exosomes for immunotherapy of cancer. , 2003, Advances in experimental medicine and biology.

[43]  H. K. Kim,et al.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.

[44]  J J Sixma,et al.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. , 1999, Blood.

[45]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[46]  D. Taylor,et al.  Shedding of plasma membrane fragments. Neoplastic and developmental importance. , 1986, Developmental biology.

[47]  G Poste,et al.  Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.